VIDEO: Immunotherapy agent induces response in prostate cancer – Healio
|
VIDEO: Immunotherapy agent induces response in prostate cancer
Healio CHICAGO — The use of sipuleucel-T in patients with hormone-sensitive and castration-resistant prostate cancer demonstrated an increase in the proliferation of CD4 and CD8 T cells at week 6 compared with baseline, according to results presented at the … |
